Jennifer Cote
Chief Financial Officer at Harvard Bioscience Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Harvard Bioscience Inc., 2 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2025 | Harvard Bioscience Inc. | Shares withheld for tax | −5,687 | $0.69 | $3,924 |
| Dec 29, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −4,731 | $1.98 | $9,367 |
| Dec 29, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −3,797 | $1.98 | $7,518 |
| Mar 6, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −9,920 | $4.11 | $40,771 |
| Mar 5, 2024 | Harvard Bioscience Inc. | Grant or award | +35,800 | — | — |
| Mar 5, 2024 | Harvard Bioscience Inc. | Grant or award | +35,800 | — | — |
| Dec 29, 2023 | Harvard Bioscience Inc. | Shares withheld for tax | −3,279 | $5.35 | $17,543 |
| Dec 29, 2023 | Harvard Bioscience Inc. | Shares withheld for tax | −2,631 | $5.35 | $14,076 |
Questions about Jennifer Cote
What boards is Jennifer Cote on?
Jennifer Cote sits on the board of Harvard Bioscience Inc.
How long has Jennifer Cote served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.